Here are some of the most important Web sites, organizations and efforts underway to bring antibodies to bear in the war against Covid-19, as well as general coverage of immunoprevention.
For those that are young, healthy and a bit adventurous, 1DaySooner.org is an organization that advocates on behalf of COVID-19 challenge trial volunteers. Human challenge trials deliberately expose participants to infection, in order to study diseases and test vaccines or treatments. They have been used for influenza, malaria, typhoid, dengue fever, and cholera. Researchers are exploring whether human challenge trials could support the development of vaccines and treatments for COVID-19.
People who have contracted and recovered from Covid-19 can volunteer here and be matched to a plasma collection center to directly help in this effort.
An international non-profit supporting antibody-related research and development, the Antibody Society, has comprehensive coverage of everything that is being conceived, developed and trialed across immunotherapy with antibodies, vaccines and drug therapies.
A website for:
- Health care providers who are considering using convalescent plasma to treat patients, either outside of a trial or in the context of a randomized trial
- Patients who have recovered from COVID-19 infection and are willing to donate plasma
- Patients with any stage of COVID-19 (or their families) who are considering this treatment
- Any member of the public interested in learning more about convalescent plasma use currently and in the past (see section on key papers).